nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—AR—type 2 diabetes mellitus	0.405	0.596	CbGaD
Cyproterone acetate—NR3C1—type 2 diabetes mellitus	0.275	0.404	CbGaD
Cyproterone acetate—AR—penis—type 2 diabetes mellitus	0.00317	0.309	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—HSD3B2—type 2 diabetes mellitus	0.0022	0.475	CrCbGaD
Cyproterone acetate—NR3C1—nerve—type 2 diabetes mellitus	0.00105	0.103	CbGeAlD
Cyproterone acetate—Megestrol acetate—NR3C1—type 2 diabetes mellitus	0.000647	0.14	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—SHBG—type 2 diabetes mellitus	0.000634	0.137	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—AR—type 2 diabetes mellitus	0.000556	0.12	CrCbGaD
Cyproterone acetate—NR3C1—islet of Langerhans—type 2 diabetes mellitus	0.000511	0.0497	CbGeAlD
Cyproterone acetate—AR—cardiovascular system—type 2 diabetes mellitus	0.00051	0.0497	CbGeAlD
Cyproterone acetate—CYP19A1—adipose tissue—type 2 diabetes mellitus	0.000508	0.0495	CbGeAlD
Cyproterone acetate—AR—kidney—type 2 diabetes mellitus	0.000499	0.0486	CbGeAlD
Cyproterone acetate—AR—cortex of kidney—type 2 diabetes mellitus	0.000486	0.0473	CbGeAlD
Cyproterone acetate—AR—adipose tissue—type 2 diabetes mellitus	0.00045	0.0438	CbGeAlD
Cyproterone acetate—NR3C1—nephron tubule—type 2 diabetes mellitus	0.000411	0.04	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—NR3C1—type 2 diabetes mellitus	0.000377	0.0813	CrCbGaD
Cyproterone acetate—NR3C1—cardiovascular system—type 2 diabetes mellitus	0.000369	0.036	CbGeAlD
Cyproterone acetate—NR3C1—kidney—type 2 diabetes mellitus	0.000361	0.0352	CbGeAlD
Cyproterone acetate—NR3C1—pancreas—type 2 diabetes mellitus	0.000359	0.035	CbGeAlD
Cyproterone acetate—CYP19A1—liver—type 2 diabetes mellitus	0.000356	0.0347	CbGeAlD
Cyproterone acetate—NR3C1—cortex of kidney—type 2 diabetes mellitus	0.000352	0.0343	CbGeAlD
Cyproterone acetate—NR3C1—adipose tissue—type 2 diabetes mellitus	0.000326	0.0317	CbGeAlD
Cyproterone acetate—AR—liver—type 2 diabetes mellitus	0.000315	0.0307	CbGeAlD
Cyproterone acetate—NR3C1—liver—type 2 diabetes mellitus	0.000228	0.0222	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—CYP3A4—type 2 diabetes mellitus	0.000219	0.0471	CrCbGaD
Cyproterone acetate—Tension—Losartan—type 2 diabetes mellitus	0.00014	0.000629	CcSEcCtD
Cyproterone acetate—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00014	0.000628	CcSEcCtD
Cyproterone acetate—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00014	0.000628	CcSEcCtD
Cyproterone acetate—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00014	0.000627	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00014	0.000627	CcSEcCtD
Cyproterone acetate—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00014	0.000626	CcSEcCtD
Cyproterone acetate—Agitation—Irbesartan—type 2 diabetes mellitus	0.00014	0.000626	CcSEcCtD
Cyproterone acetate—Urticaria—Glyburide—type 2 diabetes mellitus	0.000139	0.000623	CcSEcCtD
Cyproterone acetate—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000138	0.000621	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000138	0.00062	CcSEcCtD
Cyproterone acetate—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000138	0.00062	CcSEcCtD
Cyproterone acetate—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000138	0.000619	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000138	0.000618	CcSEcCtD
Cyproterone acetate—Anorexia—Valsartan—type 2 diabetes mellitus	0.000137	0.000616	CcSEcCtD
Cyproterone acetate—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000137	0.000615	CcSEcCtD
Cyproterone acetate—Malaise—Irbesartan—type 2 diabetes mellitus	0.000137	0.000614	CcSEcCtD
Cyproterone acetate—Headache—Pioglitazone—type 2 diabetes mellitus	0.000136	0.000611	CcSEcCtD
Cyproterone acetate—Syncope—Irbesartan—type 2 diabetes mellitus	0.000136	0.000611	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000136	0.00061	CcSEcCtD
Cyproterone acetate—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000136	0.000609	CcSEcCtD
Cyproterone acetate—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000136	0.000608	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000136	0.000608	CcSEcCtD
Cyproterone acetate—Discomfort—Metformin—type 2 diabetes mellitus	0.000135	0.000607	CcSEcCtD
Cyproterone acetate—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000135	0.000607	CcSEcCtD
Cyproterone acetate—Nausea—Glipizide—type 2 diabetes mellitus	0.000135	0.000605	CcSEcCtD
Cyproterone acetate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000135	0.000604	CcSEcCtD
Cyproterone acetate—Hypotension—Valsartan—type 2 diabetes mellitus	0.000135	0.000604	CcSEcCtD
Cyproterone acetate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000134	0.000602	CcSEcCtD
Cyproterone acetate—Constipation—Gliclazide—type 2 diabetes mellitus	0.000134	0.000602	CcSEcCtD
Cyproterone acetate—Rash—Glimepiride—type 2 diabetes mellitus	0.000134	0.000599	CcSEcCtD
Cyproterone acetate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000134	0.000599	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000133	0.000598	CcSEcCtD
Cyproterone acetate—Rash—Sitagliptin—type 2 diabetes mellitus	0.000133	0.000597	CcSEcCtD
Cyproterone acetate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000133	0.000597	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000133	0.000597	CcSEcCtD
Cyproterone acetate—Headache—Glimepiride—type 2 diabetes mellitus	0.000133	0.000595	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000133	0.000594	CcSEcCtD
Cyproterone acetate—Cough—Irbesartan—type 2 diabetes mellitus	0.000133	0.000594	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—type 2 diabetes mellitus	0.000132	0.0016	CbGpPWpGaD
Cyproterone acetate—Headache—Sitagliptin—type 2 diabetes mellitus	0.000132	0.000593	CcSEcCtD
Cyproterone acetate—Anaemia—Losartan—type 2 diabetes mellitus	0.000132	0.000592	CcSEcCtD
Cyproterone acetate—Agitation—Losartan—type 2 diabetes mellitus	0.000131	0.000589	CcSEcCtD
Cyproterone acetate—Oedema—Metformin—type 2 diabetes mellitus	0.000131	0.000589	CcSEcCtD
Cyproterone acetate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000131	0.000587	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PIK3R1—type 2 diabetes mellitus	0.00013	0.00158	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—type 2 diabetes mellitus	0.00013	0.00157	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000129	0.00058	CcSEcCtD
Cyproterone acetate—Shock—Metformin—type 2 diabetes mellitus	0.000129	0.000579	CcSEcCtD
Cyproterone acetate—Malaise—Losartan—type 2 diabetes mellitus	0.000129	0.000578	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000129	0.000577	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000129	0.000577	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000129	0.000576	CcSEcCtD
Cyproterone acetate—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000129	0.000576	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000128	0.000576	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000128	0.000575	CcSEcCtD
Cyproterone acetate—Syncope—Losartan—type 2 diabetes mellitus	0.000128	0.000575	CcSEcCtD
Cyproterone acetate—Leukopenia—Losartan—type 2 diabetes mellitus	0.000128	0.000574	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.000128	0.00155	CbGpPWpGaD
Cyproterone acetate—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000128	0.000573	CcSEcCtD
Cyproterone acetate—Skin disorder—Metformin—type 2 diabetes mellitus	0.000128	0.000572	CcSEcCtD
Cyproterone acetate—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000127	0.00057	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000127	0.000569	CcSEcCtD
Cyproterone acetate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000127	0.000569	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000127	0.000569	CcSEcCtD
Cyproterone acetate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000126	0.000567	CcSEcCtD
Cyproterone acetate—Nausea—Glimepiride—type 2 diabetes mellitus	0.000126	0.000564	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000126	0.000563	CcSEcCtD
Cyproterone acetate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000126	0.000563	CcSEcCtD
Cyproterone acetate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000125	0.000562	CcSEcCtD
Cyproterone acetate—Asthenia—Glyburide—type 2 diabetes mellitus	0.000125	0.000562	CcSEcCtD
Cyproterone acetate—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000125	0.000562	CcSEcCtD
Cyproterone acetate—Anorexia—Metformin—type 2 diabetes mellitus	0.000125	0.000561	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000125	0.00151	CbGpPWpGaD
Cyproterone acetate—Cough—Losartan—type 2 diabetes mellitus	0.000125	0.000559	CcSEcCtD
Cyproterone acetate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000125	0.000559	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000125	0.000558	CcSEcCtD
Cyproterone acetate—Alopecia—Ramipril—type 2 diabetes mellitus	0.000124	0.000558	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000124	0.00151	CbGpPWpGaD
Cyproterone acetate—Fatigue—Valsartan—type 2 diabetes mellitus	0.000124	0.000557	CcSEcCtD
Cyproterone acetate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000124	0.000556	CcSEcCtD
Cyproterone acetate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000124	0.000556	CcSEcCtD
Cyproterone acetate—Oedema—Irbesartan—type 2 diabetes mellitus	0.000124	0.000556	CcSEcCtD
Cyproterone acetate—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000124	0.000555	CcSEcCtD
Cyproterone acetate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000124	0.000554	CcSEcCtD
Cyproterone acetate—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000123	0.000553	CcSEcCtD
Cyproterone acetate—Constipation—Valsartan—type 2 diabetes mellitus	0.000123	0.000553	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000123	0.000552	CcSEcCtD
Cyproterone acetate—Fatigue—Orlistat—type 2 diabetes mellitus	0.000123	0.000551	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—RELA—type 2 diabetes mellitus	0.000123	0.00149	CbGpPWpGaD
Cyproterone acetate—Hypotension—Metformin—type 2 diabetes mellitus	0.000123	0.00055	CcSEcCtD
Cyproterone acetate—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000123	0.000549	CcSEcCtD
Cyproterone acetate—Shock—Irbesartan—type 2 diabetes mellitus	0.000122	0.000547	CcSEcCtD
Cyproterone acetate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000122	0.000545	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000122	0.000545	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000121	0.000544	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	0.000121	0.00147	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000121	0.000542	CcSEcCtD
Cyproterone acetate—Rash—Bromocriptine—type 2 diabetes mellitus	0.000121	0.000541	CcSEcCtD
Cyproterone acetate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00054	CcSEcCtD
Cyproterone acetate—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00012	0.00054	CcSEcCtD
Cyproterone acetate—Tension—Ramipril—type 2 diabetes mellitus	0.00012	0.000539	CcSEcCtD
Cyproterone acetate—Discomfort—Losartan—type 2 diabetes mellitus	0.00012	0.000539	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00012	0.000537	CcSEcCtD
Cyproterone acetate—Headache—Bromocriptine—type 2 diabetes mellitus	0.00012	0.000537	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.00012	0.00145	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00012	0.000536	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	0.000119	0.00143	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000118	0.00143	CbGpPWpGaD
Cyproterone acetate—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000118	0.00053	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000118	0.000529	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MMP1—type 2 diabetes mellitus	0.000118	0.00143	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000117	0.000526	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000117	0.00142	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000117	0.00142	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000117	0.000525	CcSEcCtD
Cyproterone acetate—Oedema—Losartan—type 2 diabetes mellitus	0.000117	0.000523	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000117	0.000522	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—LPL—type 2 diabetes mellitus	0.000116	0.00141	CbGpPWpGaD
Cyproterone acetate—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000116	0.000519	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000116	0.000518	CcSEcCtD
Cyproterone acetate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000116	0.000518	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	0.000116	0.0014	CbGpPWpGaD
Cyproterone acetate—Shock—Losartan—type 2 diabetes mellitus	0.000115	0.000514	CcSEcCtD
Cyproterone acetate—Urticaria—Valsartan—type 2 diabetes mellitus	0.000115	0.000514	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000114	0.000513	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000114	0.000512	CcSEcCtD
Cyproterone acetate—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000114	0.000512	CcSEcCtD
Cyproterone acetate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000114	0.000511	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—type 2 diabetes mellitus	0.000114	0.00138	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Losartan—type 2 diabetes mellitus	0.000114	0.00051	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000114	0.00138	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000114	0.00051	CcSEcCtD
Cyproterone acetate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000114	0.000509	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000113	0.000508	CcSEcCtD
Cyproterone acetate—Fatigue—Metformin—type 2 diabetes mellitus	0.000113	0.000508	CcSEcCtD
Cyproterone acetate—Urticaria—Orlistat—type 2 diabetes mellitus	0.000113	0.000508	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000113	0.000506	CcSEcCtD
Cyproterone acetate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000113	0.000505	CcSEcCtD
Cyproterone acetate—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000113	0.000505	CcSEcCtD
Cyproterone acetate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000113	0.000505	CcSEcCtD
Cyproterone acetate—Agitation—Ramipril—type 2 diabetes mellitus	0.000113	0.000505	CcSEcCtD
Cyproterone acetate—Constipation—Metformin—type 2 diabetes mellitus	0.000112	0.000503	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	0.000112	0.00135	CbGpPWpGaD
Cyproterone acetate—Anorexia—Losartan—type 2 diabetes mellitus	0.000111	0.000498	CcSEcCtD
Cyproterone acetate—Vomiting—Glyburide—type 2 diabetes mellitus	0.000111	0.000498	CcSEcCtD
Cyproterone acetate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000111	0.000498	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	0.000111	0.00134	CbGpPWpGaD
Cyproterone acetate—Malaise—Ramipril—type 2 diabetes mellitus	0.000111	0.000495	CcSEcCtD
Cyproterone acetate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000111	0.000495	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.00011	0.00134	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.00011	0.00134	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	0.00011	0.00133	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	0.00011	0.00133	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	0.00011	0.00133	CbGpPWpGaD
Cyproterone acetate—Rash—Glyburide—type 2 diabetes mellitus	0.00011	0.000494	CcSEcCtD
Cyproterone acetate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00011	0.000494	CcSEcCtD
Cyproterone acetate—Syncope—Ramipril—type 2 diabetes mellitus	0.00011	0.000493	CcSEcCtD
Cyproterone acetate—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00011	0.000492	CcSEcCtD
Cyproterone acetate—Headache—Glyburide—type 2 diabetes mellitus	0.00011	0.000491	CcSEcCtD
Cyproterone acetate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000109	0.000489	CcSEcCtD
Cyproterone acetate—Hypotension—Losartan—type 2 diabetes mellitus	0.000109	0.000489	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000109	0.00132	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000108	0.000485	CcSEcCtD
Cyproterone acetate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000108	0.000483	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000108	0.000483	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTM1—type 2 diabetes mellitus	0.000107	0.0013	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000107	0.000481	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000107	0.000481	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000107	0.00048	CcSEcCtD
Cyproterone acetate—Cough—Ramipril—type 2 diabetes mellitus	0.000107	0.000479	CcSEcCtD
Cyproterone acetate—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000107	0.000479	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000106	0.000476	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	0.000106	0.00129	CbGpPWpGaD
Cyproterone acetate—Constipation—Irbesartan—type 2 diabetes mellitus	0.000106	0.000475	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	0.000106	0.00128	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000105	0.000471	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	0.000105	0.00127	CbGpPWpGaD
Cyproterone acetate—Urticaria—Metformin—type 2 diabetes mellitus	0.000104	0.000468	CcSEcCtD
Cyproterone acetate—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000104	0.000466	CcSEcCtD
Cyproterone acetate—Nausea—Glyburide—type 2 diabetes mellitus	0.000104	0.000466	CcSEcCtD
Cyproterone acetate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000104	0.000465	CcSEcCtD
Cyproterone acetate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000104	0.000465	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000104	0.000464	CcSEcCtD
Cyproterone acetate—Asthenia—Valsartan—type 2 diabetes mellitus	0.000103	0.000464	CcSEcCtD
Cyproterone acetate—Discomfort—Ramipril—type 2 diabetes mellitus	0.000103	0.000462	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	0.000103	0.00125	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	0.000103	0.00124	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000103	0.00046	CcSEcCtD
Cyproterone acetate—Asthenia—Orlistat—type 2 diabetes mellitus	0.000102	0.000458	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000102	0.000458	CcSEcCtD
Cyproterone acetate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000102	0.000457	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—IRS1—type 2 diabetes mellitus	0.000102	0.00123	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—type 2 diabetes mellitus	0.000101	0.00123	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000101	0.000455	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000101	0.000454	CcSEcCtD
Cyproterone acetate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000101	0.000452	CcSEcCtD
Cyproterone acetate—Fatigue—Losartan—type 2 diabetes mellitus	0.000101	0.000451	CcSEcCtD
Cyproterone acetate—Oedema—Ramipril—type 2 diabetes mellitus	0.0001	0.000448	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	0.0001	0.00121	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	9.99e-05	0.00121	CbGpPWpGaD
Cyproterone acetate—Vomiting—Gliclazide—type 2 diabetes mellitus	9.98e-05	0.000447	CcSEcCtD
Cyproterone acetate—Constipation—Losartan—type 2 diabetes mellitus	9.98e-05	0.000447	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	9.97e-05	0.00121	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	9.95e-05	0.0012	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	9.94e-05	0.0012	CbGpPWpGaD
Cyproterone acetate—Rash—Gliclazide—type 2 diabetes mellitus	9.9e-05	0.000444	CcSEcCtD
Cyproterone acetate—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.89e-05	0.000443	CcSEcCtD
Cyproterone acetate—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.87e-05	0.000442	CcSEcCtD
Cyproterone acetate—Urticaria—Irbesartan—type 2 diabetes mellitus	9.85e-05	0.000441	CcSEcCtD
Cyproterone acetate—Shock—Ramipril—type 2 diabetes mellitus	9.84e-05	0.000441	CcSEcCtD
Cyproterone acetate—Headache—Gliclazide—type 2 diabetes mellitus	9.84e-05	0.000441	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	9.83e-05	0.00119	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.81e-05	0.00044	CcSEcCtD
Cyproterone acetate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.8e-05	0.000439	CcSEcCtD
Cyproterone acetate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.8e-05	0.000439	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.79e-05	0.000439	CcSEcCtD
Cyproterone acetate—Tachycardia—Ramipril—type 2 diabetes mellitus	9.76e-05	0.000438	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	9.75e-05	0.00118	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.75e-05	0.000437	CcSEcCtD
Cyproterone acetate—Skin disorder—Ramipril—type 2 diabetes mellitus	9.72e-05	0.000436	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.67e-05	0.000433	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—SRC—type 2 diabetes mellitus	9.65e-05	0.00117	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	9.62e-05	0.00116	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.61e-05	0.000431	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP8—type 2 diabetes mellitus	9.59e-05	0.00116	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.54e-05	0.000428	CcSEcCtD
Cyproterone acetate—Dizziness—Valsartan—type 2 diabetes mellitus	9.54e-05	0.000428	CcSEcCtD
Cyproterone acetate—Anorexia—Ramipril—type 2 diabetes mellitus	9.53e-05	0.000427	CcSEcCtD
Cyproterone acetate—Dizziness—Orlistat—type 2 diabetes mellitus	9.42e-05	0.000422	CcSEcCtD
Cyproterone acetate—Asthenia—Metformin—type 2 diabetes mellitus	9.42e-05	0.000422	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	9.42e-05	0.00114	CbGpPWpGaD
Cyproterone acetate—Hypotension—Ramipril—type 2 diabetes mellitus	9.35e-05	0.000419	CcSEcCtD
Cyproterone acetate—Nausea—Gliclazide—type 2 diabetes mellitus	9.33e-05	0.000418	CcSEcCtD
Cyproterone acetate—Pruritus—Metformin—type 2 diabetes mellitus	9.29e-05	0.000417	CcSEcCtD
Cyproterone acetate—Urticaria—Losartan—type 2 diabetes mellitus	9.27e-05	0.000415	CcSEcCtD
Cyproterone acetate—Abdominal pain—Losartan—type 2 diabetes mellitus	9.22e-05	0.000413	CcSEcCtD
Cyproterone acetate—Body temperature increased—Losartan—type 2 diabetes mellitus	9.22e-05	0.000413	CcSEcCtD
Cyproterone acetate—Vomiting—Valsartan—type 2 diabetes mellitus	9.17e-05	0.000411	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.13e-05	0.000409	CcSEcCtD
Cyproterone acetate—Rash—Valsartan—type 2 diabetes mellitus	9.09e-05	0.000408	CcSEcCtD
Cyproterone acetate—Dermatitis—Valsartan—type 2 diabetes mellitus	9.09e-05	0.000407	CcSEcCtD
Cyproterone acetate—Vomiting—Orlistat—type 2 diabetes mellitus	9.06e-05	0.000406	CcSEcCtD
Cyproterone acetate—Headache—Valsartan—type 2 diabetes mellitus	9.04e-05	0.000405	CcSEcCtD
Cyproterone acetate—Diarrhoea—Metformin—type 2 diabetes mellitus	8.99e-05	0.000403	CcSEcCtD
Cyproterone acetate—Rash—Orlistat—type 2 diabetes mellitus	8.99e-05	0.000403	CcSEcCtD
Cyproterone acetate—Dermatitis—Orlistat—type 2 diabetes mellitus	8.98e-05	0.000402	CcSEcCtD
Cyproterone acetate—Headache—Orlistat—type 2 diabetes mellitus	8.93e-05	0.0004	CcSEcCtD
Cyproterone acetate—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.92e-05	0.0004	CcSEcCtD
Cyproterone acetate—Asthenia—Irbesartan—type 2 diabetes mellitus	8.89e-05	0.000399	CcSEcCtD
Cyproterone acetate—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.8e-05	0.000395	CcSEcCtD
Cyproterone acetate—Pruritus—Irbesartan—type 2 diabetes mellitus	8.77e-05	0.000393	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—IRS1—type 2 diabetes mellitus	8.75e-05	0.00106	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	8.7e-05	0.00105	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.7e-05	0.00039	CcSEcCtD
Cyproterone acetate—Dizziness—Metformin—type 2 diabetes mellitus	8.69e-05	0.000389	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.64e-05	0.000387	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	8.64e-05	0.00104	CbGpPWpGaD
Cyproterone acetate—Fatigue—Ramipril—type 2 diabetes mellitus	8.62e-05	0.000387	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.59e-05	0.000385	CcSEcCtD
Cyproterone acetate—Nausea—Valsartan—type 2 diabetes mellitus	8.57e-05	0.000384	CcSEcCtD
Cyproterone acetate—Constipation—Ramipril—type 2 diabetes mellitus	8.55e-05	0.000383	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	8.5e-05	0.00103	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.00038	CcSEcCtD
Cyproterone acetate—Nausea—Orlistat—type 2 diabetes mellitus	8.47e-05	0.000379	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EGFR—type 2 diabetes mellitus	8.46e-05	0.00102	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	8.39e-05	0.00101	CbGpPWpGaD
Cyproterone acetate—Asthenia—Losartan—type 2 diabetes mellitus	8.37e-05	0.000375	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	8.36e-05	0.00101	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	8.36e-05	0.00101	CbGpPWpGaD
Cyproterone acetate—Vomiting—Metformin—type 2 diabetes mellitus	8.35e-05	0.000374	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	8.33e-05	0.00101	CbGpPWpGaD
Cyproterone acetate—Rash—Metformin—type 2 diabetes mellitus	8.28e-05	0.000371	CcSEcCtD
Cyproterone acetate—Dermatitis—Metformin—type 2 diabetes mellitus	8.27e-05	0.000371	CcSEcCtD
Cyproterone acetate—Pruritus—Losartan—type 2 diabetes mellitus	8.25e-05	0.00037	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP8—type 2 diabetes mellitus	8.25e-05	0.000998	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.24e-05	0.000369	CcSEcCtD
Cyproterone acetate—Headache—Metformin—type 2 diabetes mellitus	8.23e-05	0.000369	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BCL2—type 2 diabetes mellitus	8.23e-05	0.000995	CbGpPWpGaD
Cyproterone acetate—Dizziness—Irbesartan—type 2 diabetes mellitus	8.2e-05	0.000367	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—BHMT—type 2 diabetes mellitus	8.2e-05	0.000992	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000367	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	8.11e-05	0.000982	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—type 2 diabetes mellitus	8.11e-05	0.000981	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	8.08e-05	0.000978	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	8.06e-05	0.000975	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	7.99e-05	0.000967	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Losartan—type 2 diabetes mellitus	7.98e-05	0.000358	CcSEcCtD
Cyproterone acetate—Urticaria—Ramipril—type 2 diabetes mellitus	7.95e-05	0.000356	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	7.94e-05	0.000961	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	7.93e-05	0.000959	CbGpPWpGaD
Cyproterone acetate—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.91e-05	0.000354	CcSEcCtD
Cyproterone acetate—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.91e-05	0.000354	CcSEcCtD
Cyproterone acetate—Vomiting—Irbesartan—type 2 diabetes mellitus	7.88e-05	0.000353	CcSEcCtD
Cyproterone acetate—Rash—Irbesartan—type 2 diabetes mellitus	7.82e-05	0.00035	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	7.81e-05	0.000945	CbGpPWpGaD
Cyproterone acetate—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.00035	CcSEcCtD
Cyproterone acetate—Nausea—Metformin—type 2 diabetes mellitus	7.8e-05	0.00035	CcSEcCtD
Cyproterone acetate—Headache—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.000348	CcSEcCtD
Cyproterone acetate—Dizziness—Losartan—type 2 diabetes mellitus	7.71e-05	0.000346	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	7.65e-05	0.000926	CbGpPWpGaD
Cyproterone acetate—Vomiting—Losartan—type 2 diabetes mellitus	7.42e-05	0.000332	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.37e-05	0.00033	CcSEcCtD
Cyproterone acetate—Nausea—Irbesartan—type 2 diabetes mellitus	7.36e-05	0.00033	CcSEcCtD
Cyproterone acetate—Rash—Losartan—type 2 diabetes mellitus	7.36e-05	0.00033	CcSEcCtD
Cyproterone acetate—Dermatitis—Losartan—type 2 diabetes mellitus	7.35e-05	0.000329	CcSEcCtD
Cyproterone acetate—Headache—Losartan—type 2 diabetes mellitus	7.31e-05	0.000328	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	7.25e-05	0.000878	CbGpPWpGaD
Cyproterone acetate—Asthenia—Ramipril—type 2 diabetes mellitus	7.18e-05	0.000322	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—AANAT—type 2 diabetes mellitus	7.16e-05	0.000867	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGDS—type 2 diabetes mellitus	7.16e-05	0.000867	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	7.14e-05	0.000864	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—type 2 diabetes mellitus	7.08e-05	0.000856	CbGpPWpGaD
Cyproterone acetate—Pruritus—Ramipril—type 2 diabetes mellitus	7.08e-05	0.000317	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	7.07e-05	0.000855	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	7e-05	0.000847	CbGpPWpGaD
Cyproterone acetate—Nausea—Losartan—type 2 diabetes mellitus	6.93e-05	0.000311	CcSEcCtD
Cyproterone acetate—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000307	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	6.82e-05	0.000825	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	6.81e-05	0.000824	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CDO1—type 2 diabetes mellitus	6.79e-05	0.000822	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPD2—type 2 diabetes mellitus	6.79e-05	0.000822	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	6.78e-05	0.000821	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NCOA6—type 2 diabetes mellitus	6.65e-05	0.000805	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	6.64e-05	0.000803	CbGpPWpGaD
Cyproterone acetate—Dizziness—Ramipril—type 2 diabetes mellitus	6.61e-05	0.000296	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	6.61e-05	0.000799	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	6.6e-05	0.000798	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AK1—type 2 diabetes mellitus	6.48e-05	0.000784	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	6.48e-05	0.000783	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	6.46e-05	0.000782	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	6.4e-05	0.000775	CbGpPWpGaD
Cyproterone acetate—Vomiting—Ramipril—type 2 diabetes mellitus	6.36e-05	0.000285	CcSEcCtD
Cyproterone acetate—Rash—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000283	CcSEcCtD
Cyproterone acetate—Dermatitis—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000282	CcSEcCtD
Cyproterone acetate—Headache—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000281	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	6.24e-05	0.000755	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	6.16e-05	0.000745	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	6.13e-05	0.000742	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	6.02e-05	0.000728	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	6.01e-05	0.000727	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	6e-05	0.000726	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—type 2 diabetes mellitus	5.99e-05	0.000725	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC5A4—type 2 diabetes mellitus	5.98e-05	0.000723	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MAT1A—type 2 diabetes mellitus	5.98e-05	0.000723	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	5.97e-05	0.000723	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	5.95e-05	0.00072	CbGpPWpGaD
Cyproterone acetate—Nausea—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000266	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	5.84e-05	0.000707	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	5.84e-05	0.000706	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	5.79e-05	0.000701	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ENPP1—type 2 diabetes mellitus	5.77e-05	0.000699	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—G6PC—type 2 diabetes mellitus	5.77e-05	0.000699	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.77e-05	0.000699	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HBA2—type 2 diabetes mellitus	5.77e-05	0.000699	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ND1—type 2 diabetes mellitus	5.77e-05	0.000699	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	5.62e-05	0.00068	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GCGR—type 2 diabetes mellitus	5.59e-05	0.000677	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	5.54e-05	0.00067	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	5.38e-05	0.000651	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	5.36e-05	0.000649	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	5.31e-05	0.000642	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	5.3e-05	0.000641	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYTB—type 2 diabetes mellitus	5.28e-05	0.000639	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—OXCT1—type 2 diabetes mellitus	5.28e-05	0.000639	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	5.28e-05	0.000639	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	5.26e-05	0.000637	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	5.24e-05	0.000634	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SRD5A1—type 2 diabetes mellitus	5.15e-05	0.000623	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	5.14e-05	0.000622	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	5.1e-05	0.000617	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	5.05e-05	0.000611	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	5.01e-05	0.000607	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	4.95e-05	0.000599	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	4.95e-05	0.000599	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACACA—type 2 diabetes mellitus	4.91e-05	0.000594	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HSD17B3—type 2 diabetes mellitus	4.91e-05	0.000594	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—STAR—type 2 diabetes mellitus	4.91e-05	0.000594	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	4.9e-05	0.000593	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	4.86e-05	0.000588	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	4.83e-05	0.000585	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	4.77e-05	0.000577	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CBS—type 2 diabetes mellitus	4.71e-05	0.00057	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCC8—type 2 diabetes mellitus	4.71e-05	0.00057	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	4.68e-05	0.000566	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	4.59e-05	0.000555	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	4.56e-05	0.000552	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	4.55e-05	0.00055	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HNF4A—type 2 diabetes mellitus	4.53e-05	0.000549	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—COX2—type 2 diabetes mellitus	4.53e-05	0.000548	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC5A2—type 2 diabetes mellitus	4.53e-05	0.000548	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	4.51e-05	0.000546	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NCOA6—type 2 diabetes mellitus	4.45e-05	0.000539	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	4.45e-05	0.000538	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—UCP2—type 2 diabetes mellitus	4.38e-05	0.00053	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HSD11B1—type 2 diabetes mellitus	4.38e-05	0.00053	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—UCP3—type 2 diabetes mellitus	4.38e-05	0.00053	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	4.37e-05	0.000529	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	4.24e-05	0.000513	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	4.15e-05	0.000502	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PCK1—type 2 diabetes mellitus	4.11e-05	0.000498	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	4.09e-05	0.000495	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	4.05e-05	0.00049	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—DNMT1—type 2 diabetes mellitus	3.96e-05	0.000479	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PSMD6—type 2 diabetes mellitus	3.96e-05	0.000479	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	3.95e-05	0.000478	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	3.93e-05	0.000475	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	3.9e-05	0.000472	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—CTGF—type 2 diabetes mellitus	3.89e-05	0.000471	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HK1—type 2 diabetes mellitus	3.85e-05	0.000466	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	3.85e-05	0.000466	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	3.75e-05	0.000454	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—KCNJ11—type 2 diabetes mellitus	3.72e-05	0.00045	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LPA—type 2 diabetes mellitus	3.72e-05	0.00045	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HSD3B2—type 2 diabetes mellitus	3.72e-05	0.00045	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GCKR—type 2 diabetes mellitus	3.72e-05	0.00045	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	3.68e-05	0.000446	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	3.64e-05	0.000441	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.58e-05	0.000433	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALDOB—type 2 diabetes mellitus	3.57e-05	0.000432	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.47e-05	0.000419	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	3.44e-05	0.000416	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.4e-05	0.000411	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	3.38e-05	0.000409	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH2—type 2 diabetes mellitus	3.37e-05	0.000408	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.36e-05	0.000406	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GLP1R—type 2 diabetes mellitus	3.32e-05	0.000401	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.25e-05	0.000394	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	3.15e-05	0.000381	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	3.1e-05	0.000375	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC2A2—type 2 diabetes mellitus	3.1e-05	0.000375	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTR—type 2 diabetes mellitus	3.03e-05	0.000367	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CPT1A—type 2 diabetes mellitus	3.03e-05	0.000367	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	3.01e-05	0.000364	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	3.01e-05	0.000364	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NAMPT—type 2 diabetes mellitus	2.97e-05	0.00036	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.96e-05	0.000358	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LIPC—type 2 diabetes mellitus	2.96e-05	0.000358	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HBA1—type 2 diabetes mellitus	2.96e-05	0.000358	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GCK—type 2 diabetes mellitus	2.96e-05	0.000358	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	2.95e-05	0.000357	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.94e-05	0.000355	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—CDKN2B—type 2 diabetes mellitus	2.9e-05	0.00035	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.89e-05	0.000349	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SIRT1—type 2 diabetes mellitus	2.87e-05	0.000347	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CETP—type 2 diabetes mellitus	2.85e-05	0.000345	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2.79e-05	0.000338	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.66e-05	0.000322	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PSMD6—type 2 diabetes mellitus	2.65e-05	0.000321	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SREBF1—type 2 diabetes mellitus	2.65e-05	0.000321	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SNAP25—type 2 diabetes mellitus	2.65e-05	0.000321	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CTGF—type 2 diabetes mellitus	2.6e-05	0.000315	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMGCR—type 2 diabetes mellitus	2.58e-05	0.000312	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	2.56e-05	0.000309	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.54e-05	0.000308	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR3C1—type 2 diabetes mellitus	2.54e-05	0.000308	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPP2CA—type 2 diabetes mellitus	2.53e-05	0.000306	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.52e-05	0.000305	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.43e-05	0.000293	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.4e-05	0.00029	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.4e-05	0.00029	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	2.38e-05	0.000288	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARA—type 2 diabetes mellitus	2.38e-05	0.000288	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.34e-05	0.000283	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.33e-05	0.000281	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.3e-05	0.000278	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GCG—type 2 diabetes mellitus	2.3e-05	0.000278	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	2.2e-05	0.000266	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	2.17e-05	0.000263	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.98e-05	0.00024	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GNB3—type 2 diabetes mellitus	1.98e-05	0.00024	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMOX1—type 2 diabetes mellitus	1.97e-05	0.000239	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARG—type 2 diabetes mellitus	1.97e-05	0.000238	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAT—type 2 diabetes mellitus	1.95e-05	0.000235	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.92e-05	0.000232	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOB—type 2 diabetes mellitus	1.89e-05	0.000229	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTM1—type 2 diabetes mellitus	1.84e-05	0.000222	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	1.81e-05	0.000219	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LPL—type 2 diabetes mellitus	1.8e-05	0.000218	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.77e-05	0.000215	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ADCY5—type 2 diabetes mellitus	1.77e-05	0.000214	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPX1—type 2 diabetes mellitus	1.76e-05	0.000213	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CD36—type 2 diabetes mellitus	1.71e-05	0.000207	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.69e-05	0.000205	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.62e-05	0.000197	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARA—type 2 diabetes mellitus	1.59e-05	0.000193	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AGT—type 2 diabetes mellitus	1.54e-05	0.000187	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	1.52e-05	0.000184	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	1.51e-05	0.000183	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	1.49e-05	0.000181	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	1.49e-05	0.000181	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.35e-05	0.000163	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	1.32e-05	0.000159	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	1.29e-05	0.000156	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	1.18e-05	0.000143	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	1.13e-05	0.000137	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.13e-05	0.000137	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.04e-05	0.000125	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—type 2 diabetes mellitus	7.78e-06	9.42e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	5.9e-06	7.14e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	5.21e-06	6.3e-05	CbGpPWpGaD
